Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • 2025-05
  • 2025-04
  • 2'3'-cGAMP (Sodium Salt): Benchmark STING Agonist for Inn...

    2026-01-09

    2'3'-cGAMP (Sodium Salt): Benchmark STING Agonist for Innate Immunity Research

    Executive Summary: 2'3'-cGAMP (sodium salt) is a canonical cyclic dinucleotide produced by mammalian cGAS in response to cytosolic double-stranded DNA (dsDNA) detection (Chini et al., 2025). It directly binds the STING protein with high affinity (Kd = 3.79 nM), thus potently activating the TBK1–IRF3 signaling axis and driving type I interferon (IFN-β) induction (APExBIO, B8362). This molecule is water-soluble (≥7.56 mg/mL), chemically stable at -20°C, and is widely used to model cGAS-STING pathway responses in cancer, infectious disease, and inflammation research (see advanced mechanistic review). Chronic NAD depletion or mitochondrial DNA leakage can endogenously trigger this pathway, and 2'3'-cGAMP is essential for mechanistic dissection and experimental modulation (Chini et al., 2025).

    Biological Rationale

    2'3'-cGAMP is an endogenous second messenger generated by cGAS when cytosolic dsDNA is present, signaling potential infection or cellular damage (Chini et al., 2025). Activation of the cGAS-STING pathway is fundamental for innate immune detection of pathogens and damaged self-DNA. Upon activation, STING initiates a cascade culminating in type I interferon production, which is critical for antiviral and antitumor responses. Dysregulation of this pathway is linked to autoinflammatory syndromes, cancer immune evasion, and age-associated inflammation.

    Mechanism of Action of 2'3'-cGAMP (sodium salt)

    2'3'-cGAMP (sodium salt) is chemically defined as adenylyl-(3'→5')-2'-guanylic acid, cyclic nucleotide, disodium salt (C20H22N10Na2O13P2; MW 718.37). It binds STING with nanomolar affinity (Kd = 3.79 nM), surpassing bacterial cyclic dinucleotides in potency (APExBIO, B8362). Upon binding, STING translocates from the endoplasmic reticulum to the Golgi apparatus, recruiting and activating TANK-binding kinase 1 (TBK1). TBK1 phosphorylates the transcription factor IRF3, leading to nuclear translocation and upregulation of IFN-β and related genes. This signaling axis is tightly regulated and can be triggered by endogenous (e.g., mitochondrial DNA leakage) or exogenous (pathogen-derived) DNA (Chini et al., 2025).

    Evidence & Benchmarks

    • 2'3'-cGAMP activates STING with a dissociation constant (Kd) of 3.79 nM in vitro, demonstrating the highest affinity among tested cyclic dinucleotides (APExBIO B8362).
    • Chronic NAD depletion in NIH3T3 fibroblasts results in cytosolic mitochondrial DNA leakage, activating the cGAS-STING pathway and leading to increased interferon gene expression (Chini et al., 2025).
    • Inhibition of STING signaling with H-151 blocks interferon gene upregulation, confirming STING dependence of the response (Chini et al., 2025).
    • 2'3'-cGAMP (sodium salt) is soluble in water at ≥7.56 mg/mL, but insoluble in ethanol and DMSO, supporting its utility in aqueous cell-based systems (APExBIO B8362).
    • For storage, -20°C preserves compound stability and biological activity for extended periods (APExBIO B8362).

    Applications, Limits & Misconceptions

    2'3'-cGAMP (sodium salt) is a gold-standard tool for dissecting the cGAS-STING pathway in basic and translational research. It underpins studies of:

    • Innate immune signaling mechanisms in response to cytosolic DNA.
    • Therapeutic targeting of the STING-TBK1-IRF3 pathway in cancer immunotherapy and antiviral strategies.
    • Screening and validation of STING modulators and antagonists.
    • Modeling chronic inflammatory states, including those driven by mitochondrial dysfunction and age-related NAD decline.

    For a unique analysis of endothelial STING signaling and tumor vasculature normalization, see this in-depth article, which this review expands by providing quantitative affinity and solubility data and explicit application boundaries. For advanced mechanistic insights on cell-type–specific STING agonism, consult this pharmacology-focused resource; the present article synthesizes and updates those findings with new evidence from chronic NAD depletion models. For strategic and translational context, this thought-leadership piece complements our practical emphasis on experimental parameters.

    Common Pitfalls or Misconceptions

    • 2'3'-cGAMP (sodium salt) is not cell-permeable by default; transfection or permeabilization is required for cytosolic delivery.
    • The compound does not activate non-STING pattern recognition receptors (e.g., RIG-I, TLRs).
    • It does not mimic bacterial cyclic dinucleotides; its binding mode and potency are mammalian-STING specific.
    • Biological effects are context-dependent and can be masked by upstream defects in cGAS or downstream defects in TBK1/IRF3.
    • It should not be used as a diagnostic for endogenous DNA damage without complementary assays.

    Workflow Integration & Parameters

    2'3'-cGAMP (sodium salt) from APExBIO (B8362) is provided as a solid, to be reconstituted in water. For maximum solubility, dissolve at ≥7.56 mg/mL. Avoid DMSO or ethanol, as the compound is insoluble in these solvents. Store reconstituted aliquots at -20°C, minimizing freeze-thaw cycles. For cell-based assays, deliver via electroporation, lipofection, or microinjection. Typical working concentrations range from 0.1 μM to 10 μM, depending on cell type and endpoint. Confirm STING and downstream pathway integrity prior to use. For screening applications, 2'3'-cGAMP serves as a positive control for STING agonist activity due to its high affinity and robust induction of IFN-β. Refer to the product page for detailed protocols and batch-specific data.

    Conclusion & Outlook

    2'3'-cGAMP (sodium salt) is an indispensable reagent for interrogating the cGAS-STING pathway and dissecting innate immune responses in diverse biomedical contexts. Its unique molecular features—high STING affinity, aqueous solubility, and robust benchmark data—set it apart as the standard for experimental rigor in immunotherapy and antiviral research. Ongoing studies continue to reveal new roles for cGAMP in age-related inflammation and cancer microenvironment modulation, positioning this molecule as a cornerstone of next-generation immunomodulatory strategies (Chini et al., 2025).